Zobrazeno 1 - 10
of 258
pro vyhledávání: '"type of therapy"'
Publikováno v:
Acta Médica Portuguesa, Vol 32, Iss 5, Pp 375-380 (2019)
Introduction: Type 2 diabetes is a major driver of pharmaceutical spending. We aimed to determine the proportion of new patients who begin treatment with each antidiabetic medicine class, if therapy was initiated by their family physician, if family
Externí odkaz:
https://doaj.org/article/6c9c1c6183734edd8ba88d3409f88e3d
Autor:
Simon B. K. Jensen, Christian R. Juhl, Charlotte Janus, Julie R. Lundgren, Christoffer Martinussen, Christoffer Wiingaard, Cecilie Knudsen, Ruth Frikke‐Schmidt, Bente M. Stallknecht, Jens J. Holst, Sten Madsbad, Signe S. Torekov
Publikováno v:
Jensen, S B K, Juhl, C R, Janus, C, Lundgren, J R, Martinussen, C, Wiingaard, C, Knudsen, C, Frikke-Schmidt, R, Stallknecht, B M, Holst, J J, Madsbad, S & Torekov, S S 2023, ' Weight loss maintenance with exercise and liraglutide improves glucose tolerance, glucagon response, and beta cell function ', Obesity, vol. 31, no. 4, pp. 977-989 . https://doi.org/10.1002/oby.23715
OBJECTIVE: The aim of this study was to investigate glucose tolerance, glucagon response, and beta cell function during a 1-year maintenance period with either exercise, the glucagon-like peptide-1 receptor agonist liraglutide, or the combination aft
Publikováno v:
Diabetes Research and Clinical Practice. 201
AIM: To evaluate real-life changes of glycemic parameters among flash glucose monitoring (FLASH) users who do not meet glycemic targets.METHODS: De-identified data were obtained between 2014 and 2021 from patients using FLASH uninterrupted for a 24-w
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
International Journal of Adolescence and Youth, Vol 23, Iss 2, Pp 133-144 (2018)
The main aim of the research is to study how youths affected by haemophilia, a congenital hemorrhagic chronic disease, make sense of their condition, with particular reference to the transition from early adolescence to early adulthood. We administer
Externí odkaz:
https://doaj.org/article/f4f620b616d4449ba5d3397f392c25af
Publikováno v:
東京慈恵会医科大学雑誌. 137(5):113-118
article
Publikováno v:
Skajaa, G Ø, Kampmann, U, Ovesen, P G & Fuglsang, J 2023, ' Breastfeeding and insulin requirements in women with Type 1 diabetes mellitus in the first year postpartum ', Acta Diabetologica, vol. 60, no. 7, pp. 899-906 . https://doi.org/10.1007/s00592-023-02068-1
Aims: To explore whether breastfeeding affects postpartum insulin requirements, HbA1c levels, and pregnancy weight retention in women with Type 1 Diabetes Mellitus (T1DM). Methods: This prospective study included 66 women with T1DM. The women were di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19710dbf135f8f41a328c46fb23b46c1
https://pure.au.dk/portal/da/publications/breastfeeding-and-insulin-requirements-in-women-with-type-1-diabetes-mellitus-in-the-first-year-postpartum(c63c024b-3705-45be-8ba8-7e4f2646f1f3).html
https://pure.au.dk/portal/da/publications/breastfeeding-and-insulin-requirements-in-women-with-type-1-diabetes-mellitus-in-the-first-year-postpartum(c63c024b-3705-45be-8ba8-7e4f2646f1f3).html
Publikováno v:
Diabetes Research and Clinical Practice. 200
AIMS: To explore determinants of excessive weight gain after initiation of insulin therapy in type 2 diabetes mellitus (T2DM), in particular variables identified in the pre-insulin phase.METHODS: We performed a retrospective observational interventio
Autor:
Jean Van Rampelbergh, Peter Achenbach, Richard David Leslie, Mohammad Alhadj Ali, Colin Dayan, Bart Keymeulen, Katharine R. Owen, Martin Kindermans, Frédéric Parmentier, Vincent Carlier, Roxana R. Ahangarani, Evelien Gebruers, Nicolas Bovy, Luc Vanderelst, Marcelle Van Mechelen, Pierre Vandepapelière, Christian Boitard
Background Type 1 diabetes (T1D) is a CD4+ T cell-driven autoimmune disease characterized by the destruction of insulin-producing pancreatic β-cells by CD8+ T cells. Achieving glycemic targets in T1D remains challenging in clinical practice; new tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4b8a6e613bd0f20b00a20a87d940ab8
https://biblio.vub.ac.be/vubir/firstinhuman-doubleblind-randomized-phase-1b-study-of-peptide-immunotherapy-imcy0098-in-newonset-type-1-diabetes(127c9c20-514f-4223-bb84-4343e49a3e7a).html
https://biblio.vub.ac.be/vubir/firstinhuman-doubleblind-randomized-phase-1b-study-of-peptide-immunotherapy-imcy0098-in-newonset-type-1-diabetes(127c9c20-514f-4223-bb84-4343e49a3e7a).html
Autor:
Dapa-Ckd Trial Committees, David C. Wheeler, John J.V. McMurray, C. David Sjöström, Peter Rossing, Glenn M. Chertow, Niels Jongs, Anna Maria Langkilde, Hiddo J.L. Heerspink, Robert D. Toto, Ricardo Correa-Rotter, Investigators, Bergur V. Stefánsson, Tom Greene
Publikováno v:
Lancet Diabetes & Endocrinology, 9(11), 743-754. ELSEVIER SCIENCE INC
BACKGROUND: Dapagliflozin reduced the risk of kidney failure in patients with chronic kidney disease with and without type 2 diabetes in the DAPA-CKD trial. In this pre-specified analysis, we assessed the effect of dapagliflozin on the rate of change